Gene · 6143
Papers1,583
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,583
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual PI3K/mTOR inhibitor NVP-BEZ235 induces cell cycle arrest via autophagy mediated protein degradation of RPL19 in nephroblastoma cell. | Front Pharmacol | 2025 | 40771929 | PubTator, text mining | PubMed |
| Role of NRP1/HDAC4/CREB/RIPK1 Axis in SARS-CoV2 S1 Spike Subunit-Induced Neuronal Toxicity. | FASEB Bioadv | 2025 | 40746867 | PubTator, text mining | PubMed |
| Urinary exosomal FAM153C-RPL19 chimeric RNA as a diagnostic and prognostic biomarker for prostate cancer in Chinese patients. | Cancer Lett | 2025 | 40684841 | PubTator, text mining | PubMed |
| Advanced RPL19-TRAPKI-seq method reveals mechanism of action of bioactive compounds. | Nat Prod Bioprospect | 2025 | 40042546 | PubTator, text mining | PubMed |
| Exploration of RNA-binding proteins identified RPS27 as a potential regulator associated with Kaposi's sarcoma development. | BMC Cancer | 2025 | 40016701 | PubTator, text mining | PubMed |
| Exploring the Regulatory Interaction of Differentially Expressed Proteins in Cleft Palate Induced by Retinoic Acid. | Protein Pept Lett | 2025 | 39473103 | PubTator, text mining | PubMed |
| Tripokin: A multi-specific immunocytokine for cancer immunotherapy. | Int J Cancer | 2025 | 39177452 | PubTator, text mining | PubMed |
| Significant Genes Associated with Mortality and Disease Progression in Grade II and III Glioma. | Biomedicines | 2024 | 38672212 | PubTator, text mining | PubMed |
Antennal Transcriptome Evaluation and Analysis for Odorant-Binding Proteins, Chemosensory Proteins, and Suitable Reference Genes in the Leaf Beetle Pest Diorhabda rybakowi Weise (Coleoptera: Chrysomelidae). | Insects | 2024 | 38667381 | PubTator, text mining | PubMed |
| Nanosphere pharmacodynamics improves safety of immunostimulatory cytokine therapy. | iScience | 2024 | 38303687 | PubTator, text mining | PubMed |
| Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected. | BMC Infect Dis | 2024 | 38287287 | PubTator, text mining | PubMed |
| Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics. | Sci Rep | 2024 | 38238321 | PubTator, text mining | PubMed |
| VE-cadherin junction dynamics in initial lymphatic vessels promotes lymph node metastasis. | Life Sci Alliance | 2024 | 38148112 | PubTator, text mining | PubMed |
| Lysine tRNA fragments and miR-194-5p co-regulate hepatic steatosis via β-Klotho and perilipin 2. | Mol Metab | 2024 | 38141848 | PubTator, text mining | PubMed |
| Phoenixin-14 as a novel direct regulator of porcine luteal cell functions†. | Biol Reprod | 2024 | 37815939 | PubTator, text mining | PubMed |
| MicroRNA profiling of low concentration extracellular vesicle RNA utilizing NanoString nCounter technology. | J Extracell Biol | 2023 | 38938446 | PubTator, text mining | PubMed |
| Kinase Insert Domain Receptor Q472H Pathogenic Germline Variant Impacts Melanoma Tumor Growth and Patient Treatment Outcomes. | Cancers (Basel) | 2023 | 38201446 | PubTator, text mining | PubMed |
| PGF2α induces a pro-labour phenotypical switch in human myometrial cells that can be inhibited with PGF2α receptor antagonists. | Front Pharmacol | 2023 | 38155905 | PubTator, text mining | PubMed |
| Soybean 40S Ribosomal Protein S8 (GmRPS8) Interacts with 6K1 Protein and Contributes to Soybean Susceptibility to Soybean Mosaic Virus. | Viruses | 2023 | 38140603 | PubTator, text mining | PubMed |
| The Link of mRNA and rRNA Transcription by PUF60/FIR through TFIIH/P62 as a Novel Therapeutic Target for Cancer. | Int J Mol Sci | 2023 | 38139171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6143/papers?page=2